Clinical Trial Update: Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2 [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial evaluating nintedanib in lung transplant recipients with bronchiolitis obliterans syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lung-transplant Recipients | Phase 3 | Status: COMPLETED